Ignite Creation Date:
2024-05-06 @ 2:44 PM
Last Modification Date:
2024-10-26 @ 1:36 PM
Study NCT ID:
NCT04416100
Status:
UNKNOWN
Last Update Posted:
2020-12-02
First Post:
2020-05-26
Brief Title:
Development of Interstitial Lung Disease ILD in Patients With Severe SARS-CoV-2 Infection COVID-19
Sponsor:
Organization:
Medical University Innsbruck
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Collection of peripheral blood will be done in the context of a routine blood draw in all study participants in addition for immunofibrotic phenotyping at our study centre at indicated time-points
Enrollment Count:
130
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 65441 |
Who Masked List: